Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs remifentanil for recovery discharge in posterior lumbar spine fusion surgery
IRCT2014102819715N1Phase 2Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Dec 2014
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dexmedetomidine and remifentanil (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Time to discharge from recovery room. Started Dec 2014; status: completed.
02
Drugs
dexmedetomidineremifentanil
Beyond the preview
Go deeper on IRCT2014102819715N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014102819715N1.